Biotechnology

Samsung Biologics Reports Second Quarter 2022 Financial Results

* Released consolidated financial position of the company based on its full acquisition of Samsung Bioepis completed onApril 20, 2022 * Achieved record-high semi-annual revenue exceeding KRW 1 trillion * Recorded Q2'22 revenue of KRW 503.7 billion for the company's CDMO business * Recorded ...

2022-07-27 14:43 1942

Brii Biosciences Announces Positive Data Demonstrating its Long-Acting COVID-19 Neutralizing Antibody Therapy, Amubarvimab/Romlusevimab Combination, Retains Neutralizing Activity Against Live Omicron Virus BA.4/5 and BA.2.12.1 Subvariants

Independent lab results demonstrate that the combination therapy retains neutralizing activity against currently dominant COVID-19 strains, as previously demonstrated with all variants of concern to date The amubarvimab/romlusevimab combination is commercially available in China and is under rev...

2022-07-27 07:00 3165

Vela Diagnostics Develops PCR-based Test for Detecting Monkeypox Virus

SINGAPORE, July 26, 2022 /PRNewswire/ --  Vela Diagnostics announced that it has developed a PCR test kit to detect the monkeypox virus (MPXV), for research use only (RUO). The ViroKey® MPXV PCR Test allows for the prompt, in vitro detection of MPXV DNA from human skin lesion specimens. It is co...

2022-07-26 22:09 2419

Menarini Silicon Biosystems and DIESSE announced strategic partnership to distribute CHORUS TRIO in North America

The commercial agreement to promote and sell CHORUS TRIO immunometric assay solutions in the U.S. Market was announced jointly by the two companies during the AACC Annual Scientific Meeting & Clinical Lab Expo inChicago. CHICAGO, July 26, 2022 /PRNewswire/ -- Menarini Silicon Biosystems Inc, a US...

2022-07-26 21:00 1852

Vela Diagnostics Develops PCR-based Test for Detecting Monkeypox Virus

SINGAPORE, July 26, 2022 /PRNewswire/ -- Vela Diagnostics announced that it has developed a PCR test kit to detect the monkeypox virus (MPXV), for research use only (RUO). The ViroKey® MPXV PCR Test allows for the prompt, in vitro detection of MPXV DNA from human skin lesion specimens. It is com...

2022-07-26 21:00 2160

Gracell Biotechnologies to Participate in BTIG 2022 Biotechnology Conference

SAN DIEGO, Calif., and SUZHOU and SHANGHAI, China, July 26, 2022 /PRNewswire/ -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) ("Gracell"), a global clinical-stage biopharmaceutical company dedicated to discovering and developing highly efficacious and affordable cell therapies for the treatment o...

2022-07-26 20:30 1709

Novavax Announces Expanded Approval of Nuvaxovid™ COVID-19 Vaccine for Adolescents Aged 12 through 17 in Japan

* Nuvaxovid™ is the first protein-based COVID-19 vaccine approved for use in adolescents inJapan GAITHERSBURG, Md., July 26, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious d...

2022-07-26 20:05 2346

Novavax Nuvaxovid™ COVID-19 Vaccine Granted Provisional Registration in Australia for Use in Adolescents Aged 12 Through 17

* Nuvaxovid™ is the first protein-based COVID-19 vaccine available for use in adolescents aged 12 through 17 inAustralia GAITHERSBURG, Md., July 26, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines fo...

2022-07-26 20:00 1913

Henlius HANQUYOU Received TGA Approval in Australia

SHANGHAI, July 26, 2022 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) announced that the company's business partner Cipla Limited ("Cipla") has received the relevant registration certificates from the Therapeutic Goods Administration ofAustralia ("TGA") for the approval of Henlius' sel...

2022-07-26 18:03 3036

Nuance Pharma announces the completion of dosing for all NTM-001 Phase 1 clinical study participants in HKU Clinical Trials Centre

* All 16 healthy normal volunteers (HNVs) were dosed and no serious adverse event was reported * The NTM-001 Phase I clinical study is expected to be completed by the end of 2022 SHANGHAI, July 26, 2022 /PRNewswire/ -- Nuance Pharma ("the Company") announces the completion of dosing for all H...

2022-07-26 17:04 2076

Largest-Ever Industry Report Reveals Video Meetings 3x More Effective and Companies Using Them Most Gain Advantage

Data from over 130 million quarterly HCP-field interactions across 80% of global biotech and pharma companies unveiled in Veeva Pulse Field Trends Report Industrywide data shows frequent use of key digital channels is vital for effective HCP engagement PLEASANTON, Calif., July 26, 2022 /PRNewswi...

2022-07-26 09:17 2030

Angel Yeast Partners with PhaBuilder to Open PHA Factory

YICHANG, China, July 25, 2022 /PRNewswire/ -- Angel Yeast  (SH600298), a globally listed yeast and yeast extract manufacturer, has inked an agreement with Bejing PhaBuilder Biotechnology Co., Ltd (PhaBuilder) in Yichang,Hubei province to build a large manufacturing ba...

2022-07-25 23:00 3402

Ascentage Pharma and Tanner Pharma Group Initiate a Global Innovative Named Patient Program

SUZHOU, China and ROCKVILLE, Md. and CHARLOTTE, N.C., July 25, 2022 /PRNewswire/ --Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, andTanner Ph...

2022-07-25 21:59 2327

Anti-PD-1 monoclonal antibody Puyouheng™ (HX-008, Pucotenlimab injection) Co-developed by LEPU BIOPHARMA and HANX BIOPHARMACEUTICALS was approved for marketing in China by NMPA

HANGZHOU, China, July 25, 2022 /PRNewswire/ -- Anti-PD-1 monoclonal antibody – PuyouhengTM (HX-008, pucotenlimab injection), was conditionally approved by the National Medical Products Administration (NMPA) for marketing inChina to treat patients with unresectable or metastatic microsatellite ins...

2022-07-25 18:47 1979

Rona Therapeutics Announces Exclusive Licensing Transaction from Sanofi for its Broad siRNA Therapeutic Portfolio and Technology Platform

* Rona to advance worldwide development of Sanofi siRNA portfolio targeting liver and other tissues * Rona licensed Sanofi's siRNA platform to enable discovery programs in expanded therapeutic areas including neuro and muscular diseases, for which Sanofi has an exclusive option to acquire neu...

2022-07-25 12:30 2590

Biotech Company RemeGen Commemorates International Self-Care Day with Health Initiatives

YANTAI, China, July 25, 2022 /PRNewswire/ -- The 24th of July marks International Self Care Day, highlighting self-care as an essential component of wellness. On this special day, RemeGen Co., Ltd. (9995.HK, SHA: 688331), a commercial-stage biotechnology company, advocates an active and healthy ...

2022-07-25 11:00 2008

US FDA APPROVES QBIOTICS INVESTIGATIONAL NEW DRUG APPLICATION TO INITIATE TIGILANOL TIGLATE SOFT TISSUE SARCOMA PHASE II TRIAL

* Investigational new drug (IND) approval received by QBiotics, to initiate a Phase II clinical trial investigating tigilanol tiglate in the treatment of patients with Soft Tissue Sarcoma (STS) * The open label trial will evaluate efficacy and dose ranging in patients with advanced or metasta...

2022-07-25 07:09 2444

Alterity Therapeutics: Appendix 4C - Q4 FY22 Quarterly Cash Flow Report

* Phase 2 clinical trial for ATH434 commences in New Zealand and patient enrolment begins * Regulatory approval from the U.K. and Italian regulatory agencies to proceed with the Phase 2 trial * A$4.1 million R&D Tax Incentive Scheme refund * Cash balance on 30 June 2022 of A$34.8M MELBOURN...

2022-07-22 19:25 1646

Merck Launches its Uptune Program in Asia for Collaborating with Startups

* Application period for the Merck Uptune program starts today * Topics vary from AI-enabled health and cell and gene therapy tools to innovative technologies and materials in semiconductor and smart manufacturing * Selected startups can receive funding of up to € 100,000 TAGUIG, Philippines ...

2022-07-22 15:09 5198

Congratulations! Kexing Biopharm (688136.SH) was awarded by the" Annual Top 20 Chinese Biopharmaceutical Entreprises"

SHENZHEN, China, July 21, 2022 /PRNewswire/ -- On 12 July 2022, Menet held the award ceremony of the "Annual Top 100 China's Pharmaceutical Entreprises in 2021", in which 5 sub-lists of the pharmaceutical industries had been announced. This event showcased the professionalism and influence of the...

2022-07-21 22:32 3003
1 ... 162163164165166167168 ... 307